title: The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
abstract: Polymorphism in plasminogen activator inhibitor-1 gene is suggested to be associated with an increased risk of venous thromboembolism. The aim of this study was to investigate the association of plasminogen activator inhibitor-1 gene polymorphism and its coexistence with factor-V-Leiden and prothrombin-20210 mutations in pulmonary thromboembolism. The authors investigated plasminogen activator inhibitor-1 4G/5G polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in 143 pulmonary thromboembolism patients and 181 controls. Plasminogen activator inhibitor-1 4G/4G, 4G/5G, and 5G/5G gene polymorphisms and prothrombin-20210 mutations were not different between cases and controls. Factor-V-Leiden mutation was present in 21.0% and 7.7% of the cases and controls, respectively, P = .001. Neither different plasminogen activator inhibitor-1 genotypes and 4G allele nor coexistence of the allele with factor-V-Leiden or prothrombin-20210 was associated with the risk of recurrence. As a result, plasminogen activator inhibitor-1 gene polymorphism or its concomitant presence with mentioned mutations was not found to be associated with increased risk for pulmonary thromboembolism or recurrent disease in this study.
authors.affiliation: Department of Pulmonary Medicine, Gazi University School of Medicine, Ankara, Turkey. ipek@gazi.edu.tr
authors.forename: I Kivilcim
authors.initials: IK
authors.lastname: Oguzulgen
authors.forename: E
authors.initials: E
authors.lastname: Yilmaz
authors.forename: Senay
authors.initials: S
authors.lastname: Demirtas
authors.forename: Ferda Oner
authors.initials: FO
authors.lastname: Erkekol
authors.forename: Numan
authors.initials: N
authors.lastname: Ekim
authors.forename: Nalan
authors.initials: N
authors.lastname: Demir
authors.forename: Numan
authors.initials: N
authors.lastname: Numanoglu
authors.forename: Duygu
authors.initials: D
authors.lastname: Ozel
authors.forename: Arzu
authors.initials: A
authors.lastname: Ulu
authors.forename: Nejat
authors.initials: N
authors.lastname: Akar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D005165:Factor V / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D011110:Polymorphism, Genetic; D011516:Prothrombin / Q000235:genetics*; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000235:genetics*; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D017395:Plasminogen Activator Inhibitor 1; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin